Dumeaux Lab | Dumeaux Lab
Vanessa Dumeaux

Principal Investigator
CV
Google Scholar
Email
vanessa.dumeauxobfuscate@concordia.ca

Dr. Dumeaux received her doctorate in Pharmacy in 2002 in France. She then obtained her Ph.D. in molecular epidemiology, a joint degree from the University of Tromso (Norway) and the University of Paris-South XI (France). During her PhD, she developed expertise in genomics in the group of Professeur Borresen-Dale at the Norwegian Radium Hospital which was among the pioneers in expression profiling of breast carcinomas in collaboration with groups at Stanford University. Dr Dumeaux co-initiated the post-genomic wing of the Norwegian Women and Cancer cohort to study the systems biology of breast cancer in a population-based context. She has had a long-standing interest in the development of RNA-based biomarker signatures in blood, which can be used to inform on exposure (exposome; eg. organic pollutants) and health status (eg. diagnostics of breast cancer, side-effects of radiotherapy).

During her post-doc, she visited the Department of Applied Mathematics (University of Paris Descartes) and the Laboratory of Bioinformatics and Functional Genomics (Princeton University), and finally moved to Canada in 2009 to continue her research in bioinformatics and genomics at McGill University.

Dr. Dumeaux is currently a Research Scientist at Concordia’s PERFORM Center and Biology Department in Montreal as well as a freelance consultant in data science and systems biology.

Employment, Position:

• 2019-present Affiliate Professor, Department of Biology, Concordia University

• 2017-present Senior Scientist, PERFORM Centre, Concordia University

• 2017-present Freelance Consultant, Dumeaux Data Science

• 2014-17 Research Scientist, Breast Cancer Informatics laboratory, McGill University

• 2011-14 Research Scientist, UiT The Arctic University of Norway, visiting McGill University

  • 2013-14 Associate Member,Department of Epidemiology, Biostatistics & Occupational Health
  • 2011-14 Affiliate Assistant Professor, Department of Oncology

• 2006-11 Post-Doctoral & Research Fellow, UiT The Arctic University of Norway, visiting:

  • 2009-11 Goodman Cancer Centre, McGill University
  • 2008-09 Department of Applied Mathematics, University of Paris Descartes
  • 2008 Laboratory of Bioinformatics and Functional Genomics, Princeton University
  • 2006-08 Department of Genetics, The Norwegian Radium Hospital

Education:

2005 PhD Molecular Epidemiology, University of Paris XI and The Arctic University of Norway

2002 MSc Epidemiology and Public Health, University of Bordeaux II, France

2002 Doctor in Pharmacy, University of Poitiers, France

Patents and intellectual property rights:

11/2013 Patent submitted to Patent Cooperation Treaty (PCT/NO2013/050203) Gene expression profile in diagnostics

Funding:

2020-2021 Concordia Universiy OVPGRS, Team Accelerator Program: High-resolution mapping of cancer immunity for HER2+ breast cancer patients

2019-2020 PERFORM Centre, Starting Project Funds: Contribution of the brain-gut-microbiota axis in health benefits associated with exercise

2019-2020 Concordia Universiy OVPGRS, Team Start-Up Program: High-resolution mapping of cancer immunity for HER2+ breast cancer patients

2017-22 Canadian Institutes of Health Research Project grant: DCIS-Precise: A genomics-driven model for predicting DCIS response to radiation (PI: Rakovitch, Hallett)

2015-16 European Research Council: A gene expression test in blood for breast cancer (PI: Lund)

2014-17 Canadian Cancer Society Innovation grant: Interactions between the tumor-microenvironment and the systemic response of breast cancer patients

2009-14 European Research Council: Transcriptomics in cancer epidemiology(PI: Lund)